SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $127,000 | +32.3% | 28,500 | +39.0% | 0.00% | +33.3% |
| Q1 2017 | $96,000 | -22.0% | 20,500 | +1.5% | 0.00% | -40.0% |
| Q4 2016 | $123,000 | +86.4% | 20,200 | +68.3% | 0.01% | +66.7% |
| Q3 2016 | $66,000 | +65.0% | 12,000 | -17.2% | 0.00% | +50.0% |
| Q3 2014 | $40,000 | -34.4% | 14,500 | -3.3% | 0.00% | -33.3% |
| Q2 2014 | $61,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
| Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
| WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
| BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
| Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
| Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
| BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
| HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
| BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |